Results 61 to 70 of about 129 (71)

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. [PDF]

Clin Appl Thromb Hemost, 2022
Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, Ligocki M, Jeske W, Adiguzel C, Gerotziafas GT, Fareed J.   +10 more
europepmc   +1 more source

COVID-19 Vaccine Platforms: Challenges and Safety Contemplations. [PDF]

Vaccines (Basel), 2021
Al-Jighefee HT, Najjar H, Ahmed MN, Qush A, Awwad S, Kamareddine L.   +5 more
europepmc   +1 more source

Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor. [PDF]

Oncotarget, 2014
Martins LR, Perera Y, Lúcio P, Silva MG, Perea SE, Barata JT.   +5 more
europepmc   +1 more source

Synthesis and Immunogenicity of Pseudo-Oligosaccharides Structurally Related to Repeating Units of Capsular Phosphoglycans of Human Pathogens. [PDF]

Molecules
Khatuntseva EA, Kamneva AA, Yashunsky DV, Nifantiev NE.   +3 more
europepmc   +1 more source

Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake. [PDF]

Front Immunol
Seefeld ML, Templeton EL, Lehtinen JM, Sinclair N, Yadav D, Hartwell BL.   +5 more
europepmc   +1 more source

Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection. [PDF]

Vaccines (Basel)
Qiao R, Li J, Gong J, Shao Y, Yu J, Chen Y, Lu Y, Yang L, Lin L, Hu Z, Wang P, Zhao X, Zhang W.   +12 more
europepmc   +1 more source

Tumor Antigens beyond the Human Exome. [PDF]

Int J Mol Sci
Emilius L, Bremm F, Binder AK, Schaft N, Dörrie J.   +4 more
europepmc   +1 more source

Protein Expression Platforms and the Challenges of Viral Antigen Production. [PDF]

Vaccines (Basel)
Sookhoo JRV, Schiffman Z, Ambagala A, Kobasa D, Pardee K, Babiuk S.   +5 more
europepmc   +1 more source

Personalized nanovaccines for treating solid cancer metastases. [PDF]

J Hematol Oncol
Feng T, Hu J, Wen J, Qian Z, Che G, Zhou Q, Zhu L.   +6 more
europepmc   +1 more source